Navigation Links
Medsn to Become Indegene Pharmaceutical Solutions, Inc.: Change Signifies the Success of Its Innovative Global Services Model
Date:5/14/2008

ISELIN, N.J., May 14 /PRNewswire/ -- Medsn, Inc., a leading sales training, competitive and business Intelligence and marketing services provider in the United States announced that it has changed its name to Indegene Pharmaceutical Solutions, Inc. This change reflects the company's successful integration into the Indegene Worldwide Group of companies, providing its customers with a unique hybrid global service model through its network across 11 offices in 4 continents.

Since its acquisition by the Indegene Worldwide Group in 2005, the company has brought to the US market proven development and delivery capabilities, a global talent pool of over 250, including over 125 physicians, pharmacists, and health care professionals, and geographical coverage across the nation. The unique hybrid delivery model pioneered by the company leverages its US based team of more than 25 professionals with its global production team and provides clients with superb quality, client service and ability to work within challenging budget scenarios.

Indegene Pharmaceutical Solutions, Inc. will continue to deliver services across 4 business units, including medical and regulatory solutions, training services, competitive and business intelligence and promotional medical education. Indegene's US offices will continue to be in Iselin, NJ and Los Angeles, CA with the current management and delivery teams continuing in place.

"Indegene currently engages with more than 10 of the top 20 pharmaceutical companies in the US market. As our customers are restructuring their business models and looking for innovative solutions, Indegene will continue to provide its unique hybrid global delivery solutions that address the challenges of quality, service, innovation and cost. Our proven model has been tested for over 4 years and represents the vanguard of a new global pharmaceutical solutions model," said Dr. Rajesh Nair, President and CEO of Indegene.

"We have proven a
'/>"/>

SOURCE Indegene Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. MRI finds breast cancer before it becomes dangerous
2. Lip Balm Use Can Become Addictive
3. MinuteClinic Becomes Participating Provider with Assurant Health
4. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
5. Michael Moores SiCKO Becomes the Third Highest Grossing Documentary of All Time Surpassing An Inconvenient Truth
6. SMART Association Becomes Healthcare Council Member of Smart Card Alliance
7. Smurfit-Stones Hodge, LA, Mill Becomes First to Achieve Safety Milestone
8. MU researchers studying model to learn why certain cancers become resistant to drugs
9. Frances Winfield Bremer, Wife of Ambassador L. Paul Bremer, III, to Become Spokeswoman for the National Fibromyalgia Association
10. Study reveals how stem cells decide to become either skeletal or smooth muscle
11. Dr. Dan L. Fortenbacher, O.D., FCOVD, Becomes 29th President of College of Optometrists in Vision Development (COVD); Unveils 7-Part Development Plan for Ongoing Growth
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:General Mills to Cut Sugar in Kids' Cereals 2Health News:Harris Williams & Co. Advises Verathon Inc. in its Sale to Strategic Buyer Roper Industries 2Health News:Harris Williams & Co. Advises Verathon Inc. in its Sale to Strategic Buyer Roper Industries 3Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 2Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 3Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 4Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 5Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 2Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 3Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 4Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 5
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6Prepaid Emergency Travel Announces a Unique Service That Provides Peace of Mind During Family Emergencies 53181 1Prepaid Emergency Travel Announces a Unique Service That Provides Peace of Mind During Family Emergencies 53181 2ARDS Promotes Awareness with New Campaign 53177 1ARDS Promotes Awareness with New Campaign 53177 2Immune responses to flu vaccine are diminished in lupus patients 53173 1Immune responses to flu vaccine are diminished in lupus patients 53173 2